Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

LCAT Antikörper

LCAT WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN540393
  • Target Alle LCAT Antikörper anzeigen
    LCAT (Lecithin-Cholesterol Acyltransferase (LCAT))
    Reaktivität
    Bitte anfragen
    Wirt
    • 68
    • 4
    • 2
    Kaninchen
    Klonalität
    • 70
    • 4
    Polyklonal
    Konjugat
    • 34
    • 14
    • 7
    • 4
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser LCAT Antikörper ist unkonjugiert
    Applikation
    • 70
    • 31
    • 30
    • 14
    • 13
    • 13
    • 13
    • 12
    • 6
    • 5
    • 3
    • 3
    • 2
    • 1
    Western Blotting (WB)
    Verwendungszweck
    Rabbit polyclonal antibody raised against partial recombinant Lcat.
    Immunogen
    Recombinant His fusion protein corresponding to C-terminus of mouse Lcat.
    Top Product
    Discover our top product LCAT Primärantikörper
  • Applikationshinweise
    Western Blot (1:1000)
    The optimal working dilution should be determined by the end user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    In antiserum (0.05 % sodium azide)
    Lagerung
    -20 °C,-80 °C
    Informationen zur Lagerung
    Store at -20°C or -80°C.
    Aliquot to avoid repeated freezing and thawing.
  • Hirsch-Reinshagen, Donkin, Stukas, Chan, Wilkinson, Fan, Parks, Kuivenhoven, Lütjohann, Pritchard, Wellington: "LCAT synthesized by primary astrocytes esterifies cholesterol on glia-derived lipoproteins." in: Journal of lipid research, Vol. 50, Issue 5, pp. 885-93, (2009) (PubMed).

    Mulya, Lee, Gebre, Boudyguina, Chung, Smith, Colvin, Jiang, Parks: "Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL." in: Journal of lipid research, Vol. 49, Issue 11, pp. 2390-401, (2008) (PubMed).

    Lee, Badeau, Mulya, Boudyguina, Gebre, Smith, Parks: "Functional LCAT deficiency in human apolipoprotein A-I transgenic, SR-BI knockout mice." in: Journal of lipid research, Vol. 48, Issue 5, pp. 1052-61, (2007) (PubMed).

    Furbee, Sawyer, Parks: "Lecithin:cholesterol acyltransferase deficiency increases atherosclerosis in the low density lipoprotein receptor and apolipoprotein E knockout mice." in: The Journal of biological chemistry, Vol. 277, Issue 5, pp. 3511-9, (2002) (PubMed).

    Furbee, Francone, Parks: "In vivo contribution of LCAT to apolipoprotein B lipoprotein cholesteryl esters in LDL receptor and apolipoprotein E knockout mice." in: Journal of lipid research, Vol. 43, Issue 3, pp. 428-37, (2002) (PubMed).

  • Target
    LCAT (Lecithin-Cholesterol Acyltransferase (LCAT))
    Andere Bezeichnung
    LCAT (LCAT Produkte)
    Synonyme
    AI046659 antikoerper, D8Wsu61e antikoerper, MGC82035 antikoerper, lcat antikoerper, MGC88964 antikoerper, LCAT antikoerper, lecithin-cholesterol acyltransferase antikoerper, lecithin cholesterol acyltransferase antikoerper, lecithin-cholesterol acyltransferase L homeolog antikoerper, solute carrier family 12 member 4 antikoerper, fragile site, aphidicolin type, common, fra(13)(q13.2) antikoerper, LCAT antikoerper, Lcat antikoerper, lcat.L antikoerper, lcat antikoerper, SLC12A4 antikoerper, FRA13A antikoerper
    Pathways
    Lipid Metabolism
Sie sind hier:
Kundenservice